Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Hepatitis A and B are the most common vaccine-preventable ... with nearly all subjects developing hepatitis A antibodies (anti-HAV) within 2 weeks. [3] However, a second dose of vaccine, given ...

These scientists sought to answer a simple question. They ended up stumbling upon a discovery that could pave the way for a ...

From protecting against infections for people who had a solid organ or bone marrow transplant to treating hepatitis B ...

Vaccination plays a pivotal role in a child's early development by protecting them from serious illnesses. Here, the expert ...

By: Dr. Supriya Puranik The protection a baby receives starts even before birth. While pregnant, a mother does not only give ...

Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...

Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find ...

Thousands of children, women and senior citizens in Calbayog, Samar are set to receive various vaccines as part of the ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...